Ignite Creation Date:
2024-05-06 @ 3:48 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04761874
Status:
COMPLETED
Last Update Posted:
2021-04-22
First Post:
2021-02-15
Brief Title:
Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic
Sponsor:
University of Minnesota
Organization:
University of Minnesota
Study Overview
Official Title:
TELEstroke to CAre for STroke Patients at a Comprehensive Stroke Center During the COVID-19 Pandemic
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TELECAST-CSC
Brief Summary:
TELEstroke to CAre for STroke Patients at a Comprehensive Stroke Center TELECAST-CSC during the COVID-19 pandemic is a pre-post study evaluating guideline-based acute ischemic stroke care following the implementation of inpatient telestroke at a comprehensive stroke center during the COVID-19 global pandemic TELECAST-CSC compares two cohorts the in-person phase December 1 2019-March 15 2020 when all inpatient stroke team care was delivered conventionally in-person and the telestroke phase March 16 2020-June 29 2020 when all inpatient stroke team care was delivered exclusively via telestroke as part of our healthcare systems pandemic response We studied the following primarily clinical endpoints diagnostic stroke evaluation secondary stroke prevention health screening and evaluation stroke education mortality and stroke recurrence and readmission rates
Detailed Description:
The SARS-Cov-2 virus originated in Wuhan China in 2019 and rapidly became a global pandemic Beyond the pandemic stroke care is further impacted directly by COVID-19-induced systemic inflammatory response and coagulopathy which leads to increased risk of embolic stroke and intracranial hemorrhage
In the United States the highest level of stroke care is provided to the most critically ill stroke patients at comprehensive stroke centers CSCs Many CSCs also utilize telestroke to deliver remote stroke care externally to partnering spoke hospitals without local stroke expertise in order to improve time-sensitive emergent stroke interventions such as thrombolysis and thrombectomy Conceptually telestroke may also surmount pandemic-related barriers to stroke care delivery internally at CSCs and workflows incorporating telestroke have been adopted out of necessity However the efficacy of remote patient care via telestroke for stroke patients hospitalized at CSCs remains unclear The aim of the TELECAST-CSC trial was to prospectively evaluate whether inpatient stroke specialist care provided via telestroke was equivalent to stroke care provided in-person during the COVID-19 pandemic
TELECAST-CSC compares two cohorts the in-person phase December 1 2019-March 15 2020 when all inpatient stroke team care was delivered conventionally in-person and the telestroke phase March 16 2020-June 29 2020 when all inpatient stroke team care was delivered exclusively via telestroke as part of our healthcare systems pandemic response We studied the following primarily clinical endpoints diagnostic stroke evaluation secondary stroke prevention health screening and evaluation stroke education and stroke recurrence rates
In the United States the highest level of stroke care is provided to the most critically ill stroke patients at comprehensive stroke centers CSCs Many CSCs also utilize telestroke to deliver remote stroke care externally to partnering spoke hospitals without local stroke expertise in order to improve time-sensitive emergent stroke interventions such as thrombolysis and thrombectomy Conceptually telestroke may also surmount pandemic-related barriers to stroke care delivery internally at CSCs and workflows incorporating telestroke have been adopted out of necessity However the efficacy of remote patient care via telestroke for stroke patients hospitalized at CSCs remains unclear The aim of the TELECAST-CSC trial was to prospectively evaluate whether inpatient stroke specialist care provided via telestroke was equivalent to stroke care provided in-person during the COVID-19 pandemic
TELECAST-CSC compares two cohorts the in-person phase December 1 2019-March 15 2020 when all inpatient stroke team care was delivered conventionally in-person and the telestroke phase March 16 2020-June 29 2020 when all inpatient stroke team care was delivered exclusively via telestroke as part of our healthcare systems pandemic response We studied the following primarily clinical endpoints diagnostic stroke evaluation secondary stroke prevention health screening and evaluation stroke education and stroke recurrence rates
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None